Effect of Exercise and Education After Pneumonia (EPICC)

April 12, 2023 updated by: Winthrop University Hospital

Early Pneumonia Intervention to Prevent Chronic Complications in Patients Age 40 and Above

The mortality rate and quality of life is effected in patients with pneumonia, especially in the older population.

The end point of this study is to improve quality of life by and interventional exercise and education. Patients will be randomized at admission and enrolled into the study. They will be assessed with various performance and quality of life indicators before, during and after the study, and exercise tolerance will be assessed throughout and after.

Study Overview

Status

Terminated

Conditions

Detailed Description

The purpose of this research study is to assess improvement in functional status and quality of life of patients 40 years of age and older patients hospitalized for community acquired pneumonia and healthcare associated pneumonia with a multi-disciplinary program of exercise, education and psychological support. This study will use a randomized, controlled clinical trial design. The total number of patients enrolled will be 120, divided into two groups of 60 patients each. One group will have patients age 40 to 60 and second group will have patients age 60 and above. Stratified randomization will be done to divide these into two (control group and intervention group) equal groups with 30 patients each. The primary endpoint is improvement in quality of life indices. Secondary endpoints are improvement in functional status, change in 6 minute walk test, exercise intolerance, immunization, occult desaturation and change in body weight of patients hospitalized for community acquired pneumonia with a multi-disciplinary program of exercise, education and, psychological support. Eligibility includes age 40 and above at the time of admission, diagnosis of CAP and HCAP via radiographic and PNA symptoms, discharge to home, ability to read and sign informed consent to participate, ability to perform procedures/exercises involved in the study and ability to comprehend educational component of program.

Study Type

Interventional

Enrollment (Actual)

14

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New York
      • Mineola, New York, United States, 11501
        • Winthrop University Hosptial

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. Diagnosis of CAP or HCAP via radiographic imaging and symptoms of pneumonia Age 40 and above.
  2. Discharge to home.
  3. Ability to read and sign consent.
  4. Ability to perform in procedures/exercise.
  5. Ability to understand educational component of the program.
  6. Antibiotic administration for pneumonia within 12 hours of admission.

Exclusion Criteria:

  1. Severe lung diseases like ILD(Interstitial Lung disease), ARDS (Adult Respiratory Distress Syndrome.)
  2. Ventilator dependent patients.
  3. Discharge to nursing home.
  4. Comorbidity that could limit exercise training.
  5. Dementia, Schizophrenia or any active severe psychiatric disorder.
  6. Any Active Malignancy or diagnosis of Lung malignancy.
  7. Inability to attend program two times per week.
  8. Recent myocardial infarction within two months.
  9. Unstable angina, Heart failure (NYHA class III and IV.)
  10. Patients with pneumonia who did not receive antibiotics within 12 hours of admission.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Interventional 40-60
Interventional group aged 40-60
This group will receive the intervention aged 40-60
Active Comparator: Interventional 60 and above
Interventional group aged 60 and above
This group will receive the intervention aged 60 and above.
No Intervention: Control 40-60
Control group aged 40-60
No Intervention: Control 60 and above
Control group aged 60 and above

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
improvement in quality of life indices
Time Frame: one year
patients in the interventional group will undergo exercise and education after a pneumonia infection to see if the quality of life is effected by a rehab program
one year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
improvement in functional status
Time Frame: one year
one year
change in 6 minute walk test
Time Frame: one year
one year
exercise intolerance
Time Frame: one year
one year
immunization
Time Frame: one year
Patients will be assessed to see if education offered in the interventional group will effect compliance with vaccination.
one year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Shalinee Chawla, MD, Winthrop University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2012

Primary Completion (Actual)

December 1, 2016

Study Completion (Actual)

December 1, 2016

Study Registration Dates

First Submitted

September 20, 2012

First Submitted That Met QC Criteria

December 4, 2012

First Posted (Estimate)

December 6, 2012

Study Record Updates

Last Update Posted (Actual)

April 18, 2023

Last Update Submitted That Met QC Criteria

April 12, 2023

Last Verified

January 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • 255021-4

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pneumonia

Clinical Trials on Interventional 40-60

Subscribe